Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings What gold exposure Visionary GV 229 20260427 MBIO Mustang Bio posts far wider than expected Q4 2024 loss shares dip 123 percent on soft quarterly performance